SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Torben Noerup Nielsen who wrote (20525)5/11/1998 9:47:00 PM
From: Andrew H  Respond to of 32384
 
>>Also, there is a real problem with cancer trials. They naturally tent to enroll patients whose entire systems are already severely compromised due to the disease *and* due to unsuccessfull prior treatments.<<

This is true and the patients in this particular trial had on average failed many other treatments. Still, 37% drop out rate because of side effects is pretty steep...